Citadel Advisors’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,960
| Closed | -$17.6K | – | 15906 |
|
|
2022
Q4 | $17.6K | Sell |
2,960
-3,889
| -57% | -$23.3K | ﹤0.01% | 13239 |
|
|
2022
Q3 | $44K | Sell |
6,849
-3,025
| -31% | -$22.8K | ﹤0.01% | 11724 |
|
|
2022
Q2 | $77K | Buy |
9,874
+7,476
| +312% | +$63.6K | ﹤0.01% | 11633 |
|
|
2022
Q1 | $20K | Sell |
2,398
-10,074
| -81% | -$91.1K | ﹤0.01% | 13246 |
|
|
2021
Q4 | $121K | Buy |
12,472
+9,369
| +302% | +$126K | ﹤0.01% | 12517 |
|
|
2021
Q3 | $54K | Sell |
3,103
-6,010
| -66% | -$108K | ﹤0.01% | 13337 |
|
|
2021
Q2 | $186K | Sell |
9,113
-3,746
| -29% | -$75.4K | ﹤0.01% | 12245 |
|
|
2021
Q1 | $284K | Buy |
12,859
+9,735
| +312% | +$729K | ﹤0.01% | 10987 |
|
|
2020
Q4 | $194K | Buy |
3,124
+2,185
| +233% | +$125K | ﹤0.01% | 9756 |
|
|
2020
Q3 | $34K | Buy |
+939
| New | +$33.3K | ﹤0.01% | 9729 |
|
|
2020
Q2 | – | Sell |
-699
| Closed | -$16K | – | 10703 |
|
|
2020
Q1 | $16K | Buy |
+699
| New | +$19K | ﹤0.01% | 9352 |
|
|
2019
Q1 | – | Sell |
-1,776
| Closed | -$84K | – | 10061 |
|
|
2018
Q4 | $84K | Buy |
+1,776
| New | +$204K | ﹤0.01% | 8320 |
|
|
2018
Q2 | – | Sell |
-777
| Closed | -$194K | – | 9427 |
|
|
2018
Q1 | $194K | Sell |
777
-668
| -46% | -$183K | ﹤0.01% | 7376 |
|
|
2017
Q4 | $414K | Buy |
1,445
+1,275
| +750% | +$364K | ﹤0.01% | 5943 |
|
|
2017
Q3 | $51K | Buy |
+170
| New | +$44.4K | ﹤0.01% | 7184 |
|
|
2017
Q2 | – | Sell |
-529
| Closed | -$177K | – | 8237 |
|
|
2017
Q1 | $177K | Buy |
+529
| New | +$128K | ﹤0.01% | 6611 |
|
|
2016
Q4 | – | Sell |
-339
| Closed | -$80.8K | – | 8018 |
|
|
2016
Q3 | $118K | Buy |
339
+160
| +89% | +$42.3K | ﹤0.01% | 6585 |
|
|
2016
Q2 | $37K | Buy |
+179
| New | +$39.5K | ﹤0.01% | 6473 |
|
|
2016
Q1 | – | Sell |
-1,056
| Closed | -$282K | – | 8262 |
|
|
2015
Q4 | $443K | Buy |
1,056
+1,038
| +5,767% | +$464K | ﹤0.01% | 4624 |
|
|
2015
Q3 | $8K | Sell |
18
-344
| -95% | -$152K | ﹤0.01% | 8540 |
|
|
2015
Q2 | $182K | Buy |
362
+163
| +82% | +$74.8K | ﹤0.01% | 6441 |
|
|
2015
Q1 | $100K | Buy |
199
+11
| +6% | +$6.71K | ﹤0.01% | 6844 |
|
|
2014
Q4 | $113K | Buy |
188
+99
| +111% | +$39.7K | ﹤0.01% | 6544 |
|
|
2014
Q3 | $28K | Sell |
89
-16
| -15% | -$5.76K | ﹤0.01% | 7260 |
|
|
2014
Q2 | $41K | Sell |
105
-1,110
| -91% | -$458K | ﹤0.01% | 6892 |
|
|
2014
Q1 | $673K | Buy |
+1,215
| New | +$831K | ﹤0.01% | 3959 |
|
Other funds holding ACGN
HCM
TRCT
Citadel Advisors's ACGN Position: Q1 2023 in Review
Citadel Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,960 shares — an estimated $17.6K sold.
Citadel Advisors first reported a position in ACGN in Q1 2014 and held it in 26 quarters. The position peaked at $673K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.
- Citadel Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
- Citadel Advisors sold 2,960 Aceragen Inc shares in Q1 2023, an estimated $17.6K.
- Citadel Advisors first reported a position in Aceragen Inc in Q1 2014 and held it in 26 quarters.
- Citadel Advisors's Aceragen Inc position peaked at $673K in Q1 2014.
- 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.